PAXIL/SEROXAT - GREATEST NUMBER OF SUICIDE ATTEMPTS**NEW
**NEW
GSK Paxil Caspper Document
GlaxoSmithKline program called “Psychnet”
----
Foreword by Paul N. Jenner, Director and Vice President of Neuroscience and Strategic Product Development
----
Section 1: Towards the Second Billion -- All SSRIs Are Not the Same
----
Section 2: New Indications: Social Anxiety Disorder / Social Phobia
----
Section 3: Issues Management: Managing the Discontinuation Issue.
----
"Duration of Treatment and Depression: Relapse and Recurrence Rates"
----
"Paxil CR" Product Monograph
----
Paxil Litigation Documents
----
GSK's paxil.com... still a wealth of [dis]information
OTHER FILES/ARTICLES OF IMPORTANCE
MENATL HEALTH ADVOCATES ATTACK SEROXAT CAMPAIGNERS, LITIGANTS AND SOLICITORS
GIRLS USED AS GUINEA PIGS IN HPV TRIALS ADMITS GSK
DOCUMENT RETENTION, LETTERS TO MINISTERS, LETTERS AND EMAILS ABOUT SEROXAT AND LIST OF FOI REQUESTS
MINUTES OF MEETING BETWEEN MHRA AND BOB FIDDAMAN
PRESS RELEASE: GSK INVESTIGATION CONCLUDES
MHRA INVESTIGATION INTO GLAXOSMITHKLINE/SEROXAT
GSK SEROXAT - LETTER TO GSK FROM MHRA
GSK SEROXAT - LETTER TO TRADE ASSOCIATIONS
SUMMARY OF REGULATORY ACTION
LETTER FROM GSK CHIEF MEDICAL OFFICER TO MHRA
MHRA RESPONSE TO LETTER FROM GSK CHIEF MEDICAL OFFICER
MHRA CRITISIZED
WHO KILLED JAPANESE CULTURE?
Article By Bob Fiddaman
PAXIL STUDY 329 ALL OVER AGAIN?
Article By Bob Fiddaman
SSRi Antidepressant Drugs
Jeffrey Dach
More Seroxat related articles at http://fiddaman.blogspot.com
